Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds

https://doi.org/10.1016/0014-2999(84)90189-4Get rights and content

Abstract

Tricyclic antidepressants and selected hydroxylated metabolites were found to inhibit [3H]naltrexone binding in whole rat brain. The drug concentrations required to inhibit binding appeared to be within pharmacological relevant brain concentrations. Carbamazepine and several monoamine oxidase inhibitors (with the exception of clorgyline) were inactive in this regard. The relative potency of the tricyclic antidepressants with regard to inhibitions of opiate binding in brain did not correlate with their clinical efficiency as antidepressants, suggesting that these compounds probably do not exert their antidepressant effects through opioid peptidergic systems in brain. In addition, we found that imipramine (30 mg/kg) had antinociceptive properties, as assessed by the hot plate procedure, which were partially, but not significantly, reversed by naloxone (2 mg/kg). The possibility that opioid receptors may be involved in the analgesic properties of the tricyclic antidepressants has been discussed.

References (37)

  • A. Bite et al.

    Studies on the potentiation of the antinociceptive effect of oxotremorine by tetrabenazine in mice

    Psychopharmacologia (Berlin)

    (1974)
  • H. Blumberg et al.

    Naloxone, naltrexone, and related noroxymorphones

    Adv. Biochem. Psychopharmacol.

    (1974)
  • R. Bossa et al.

    Effect of antimitotic agents on morphine induced analgesia

  • M.S. Briley

    Alteration in brain receptors in affective disorders

  • R.N. Brogden et al.

    Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness

    Drugs

    (1978)
  • R.N. Brogden et al.

    Nomifensine: a review of its pharmacological properties and therapeutic efficacy in depressive illness

    Drugs

    (1979)
  • J. Cahn et al.

    Effects of thymoleptics on hippocampus electrical reactivity and on rhinencephalic behavior reactions to pain

  • T.J. Cicero et al.

    Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence

    J. Pharmacol. Exp. Ther.

    (1973)
  • Cited by (85)

    • Mechanisms of morphine-venlafaxine interactions in diabetic neuropathic pain model

      2015, Pharmacological Reports
      Citation Excerpt :

      Results of the previous studies have demonstrated that antidepressants affected opioidergic systems directly or indirectly. Activation of opioid receptors and increase in the endogenous opioids concentrations after acute administration of antidepressants was observed [23–26]. However, long-term administration altered the density of opioid receptors [27,28] and leaded to adaptive mechanisms in the opioidergic systems.

    • Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activation

      2011, Pharmacological Research
      Citation Excerpt :

      Although this study cannot rule out the influence of other neurotransmitters mediating MAE, such as noradrenaline or dopamine, which can also be stimulated by morphine [29,31] and regulated by 5-HT [32,33], there is good evidence that kappa receptors play a crucial role in nociception. This action could be mu-opioid receptor independent [8–34] and related to 5-HT modulation [35,36]. Our results point at new potential therapeutic applications of kappa-opioid receptor ligands and encourage new efforts in the development of ligands for these receptors as potential analgesics [37,38].

    • Antidepressants

      2009, Current Therapy in Pain
    • Antidepressants

      2008, Current Therapy in Pain: Expert Consult
    View all citing articles on Scopus
    View full text